Castanospermine
| Names | |
|---|---|
| Preferred IUPAC name (1S,6S,7R,8R,8aR)-Octahydroindolizine-1,6,7,8-tetrol | |
| Identifiers | |
| 
 | |
| 3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.127.469 | 
| EC Number | 
 | 
| KEGG | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C8H15NO4 | |
| Molar mass | 189.209 g/mol | 
| Appearance | White to off-white solid | 
| Melting point | 212 to 215 °C (414 to 419 °F; 485 to 488 K) | 
| Soluble | |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H302, H312, H332 | |
| P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, P501 | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Castanospermine is an indolizidine alkaloid first isolated from the seeds of Castanospermum australe. It is a potent inhibitor of some glucosidase enzymes and has antiviral activity in vitro and in mouse models.
The castanospermine derivative celgosivir is an antiviral drug candidate that as of 2009 was in development for possible use in treating hepatitis C virus (HCV) infection.